| 17beta-estradiol | decreases expression | ISO | RGD:1344643 | 6480464 | Estradiol results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:1344643 | 6480464 | Estradiol results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PFKFB4 mRNA | CTD | PMID:21724226 |
| 2-methylcholine | affects expression | ISO | RGD:1344643 | 6480464 | beta-methylcholine affects the expression of PFKFB4 mRNA | CTD | PMID:21179406 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PFKFB4 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:1552032 | 6480464 | Benzo(a)pyrene results in increased expression of PFKFB4 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1344643 | 6480464 | Benzo(a)pyrene results in decreased expression of PFKFB4 mRNA | CTD | PMID:21632981 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PFKFB4 mRNA | CTD | PMID:17010207 |
| choline | multiple interactions | ISO | RGD:1552032 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKFB4 mRNA | CTD | PMID:20938992 |
| cisplatin | increases expression | ISO | RGD:1344643 | 6480464 | Cisplatin results in increased expression of PFKFB4 protein | CTD | PMID:16803524 |
| cobalt atom | multiple interactions | ISO | RGD:1344643 | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of PFKFB4 mRNA | CTD | PMID:20105288 |
| cobalt atom | multiple interactions | ISO | RGD:1344643 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of PFKFB4 mRNA | CTD | PMID:18078969 |
| cobalt dichloride | increases expression | ISO | RGD:1344643 | 6480464 | cobaltous chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:20105288 |
| cobalt dichloride | multiple interactions | ISO | RGD:1344643 | 6480464 | [cobaltous chloride results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA | CTD | PMID:16025159 |
| cobalt dichloride | increases expression | ISO | RGD:1344643 | 6480464 | cobaltous chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:20105288 PMID:22202117 |
| cobalt dichloride | increases expression | ISO | RGD:1344643 | 6480464 | cobaltous chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:22202117 PMID:20105288 |
| cobalt dichloride | multiple interactions | ISO | RGD:1344643 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] | CTD | PMID:22202117 |
| curcumin | decreases expression | ISO | RGD:1344643 | 6480464 | Curcumin results in decreased expression of PFKFB4 mRNA | CTD | PMID:17198877 |
| cyclosporin A | decreases expression | ISO | RGD:1344643 | 6480464 | Cyclosporine results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1344643 | 6480464 | Cyclosporine results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 PMID:21632981 |
| desferrioxamine B | multiple interactions | ISO | RGD:1344643 | 6480464 | [Deferoxamine results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA | CTD | PMID:16025159 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of PFKFB4 mRNA | CTD | PMID:18636392 |
| dioxygen | multiple interactions | ISO | RGD:1344643 | 6480464 | Oxygen deficiency promotes the reaction [HIF1A protein results in increased expression of PFKFB4 mRNA] | CTD | PMID:16025159 |
| dioxygen | increases expression | ISO | RGD:1344643 | 6480464 | Oxygen deficiency results in increased expression of PFKFB4 protein | CTD | PMID:16025159 |
| folic acid | multiple interactions | ISO | RGD:1552032 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKFB4 mRNA | CTD | PMID:20938992 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of PFKFB4 mRNA | CTD | PMID:17010207 |
| hydralazine | multiple interactions | ISO | RGD:1344643 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:17183730 |
| iron atom | multiple interactions | ISO | RGD:1344643 | 6480464 | [cobaltous chloride results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA; more ... | CTD | PMID:16025159 |
| L-methionine | multiple interactions | ISO | RGD:1552032 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKFB4 mRNA | CTD | PMID:20938992 |
| nickel dichloride | increases expression | ISO | RGD:1344643 | 6480464 | nickel chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:21455298 |
| oxaliplatin | decreases expression | ISO | RGD:1344643 | 6480464 | oxaliplatin results in decreased expression of PFKFB4 mRNA | CTD | PMID:17762391 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of PFKFB4 mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | ISO | RGD:1552032 | 6480464 | Acetaminophen affects the expression of PFKFB4 mRNA | CTD | PMID:17562736 |
| paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of PFKFB4 mRNA | CTD | PMID:15206577 |
| quercetin | decreases expression | ISO | RGD:1344643 | 6480464 | Quercetin results in decreased expression of PFKFB4 mRNA | CTD | PMID:21632981 |
| uranium atom | affects expression | ISO | RGD:1344643 | 6480464 | Uranium affects the expression of PFKFB4 mRNA | CTD | PMID:15672453 |
| valproic acid | affects expression | ISO | RGD:1552032 | 6480464 | Valproic Acid affects the expression of PFKFB4 mRNA | CTD | PMID:17292431 |
| valproic acid | multiple interactions | ISO | RGD:1344643 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:17183730 |
| zinc dichloride | multiple interactions | ISO | RGD:1344643 | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] | CTD | PMID:22202117 |